News and features

Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.

If you’re a journalist and want to find out more, you can contact our media relations team.

ICR Logo
New targeted drugs could treat drug-resistant skin cancer

11/12/14

A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports.
ICR Logo
Celebrities support cancer research at ICR’s ‘Carols from Chelsea’

10/12/14

More than 400 people attended the sold-out event on Tuesday night which was hosted by the ICR in the beautiful Wren Chapel of the Royal Hospital, Chelsea.
white blood cell
Test assesses whether immune system is holding cancer in check

10/12/14

ICR scientists have developed a new high-tech system for measuring the body’s immune response to cancer: that combines computerised imaging of tumour samples with statistical analysis, and is the first objective method to measure the interaction between a patient’s immune system and their tumour.
ICR Logo
New software helps radiotherapy track moving tumours

07/12/14

Scientists have developed new software which can track cancers that undergo substantial movement during radiotherapy, such as lung or liver tumours.
discovery club speaker
ICR’s scientific creativity celebrated at the third annual reception of The Discovery Club

05/12/14

Our third annual gathering of the club celebrated the ICR's scientific creativity and achievements over the past year.
IMRT Kevin Harrington feature_485x364
Fine tuning radiotherapy for breakthroughs in treating bladder cancer

03/12/14

Bladder shape, capacity and position vary between individuals, making radiotherapy in patients with bladder cancer a real challenge. But now researchers at ICR are working with the bladder’s unpredictability to deliver better radiotherapy for a type of cancer that has traditionally been hard-to-treat.
ICR Logo
Highlights of the year, 2014

01/12/14

2014 has been full of exciting research results for the ICR. We have selected ten of our discoveries from the past year, which we'll publish every day over the next two weeks
ICR Logo
The Climb of Life event reaches new heights

01/12/14

The annual fundraising event has raised more than £100,000, bringing the grand total raised by the team over the last eight years to over £600,000.
Test Tubes
Blood test could pick up genetic echoes of lifestyle risk for cancer

28/11/14

A blood test could one day uncover the genetic ‘echoes’ from past activity such as smoking which could increase a person’s chance of developing cancer years later
Breast cancer cells stained for DNA (red), NFkB (green), and a reactive oxygen species probe (blue)
Scientists discover way to target rare breast cancer mutation

27/11/14

UK scientists have identified a drug to target a rare breast cancer mutation that helps drive the disease in around 900 of the 50,000 new cases of breast cancer diagnosed in the UK each year.
ICR Logo
ICR supporters take on the Berlin Marathon

27/11/14

Supporters of The Institute of Cancer Research, London, raised more than £7,000 at the Berlin Marathon for research into cancer.
Professor Paul Workman
Professor Paul Workman appointed as ICR Chief Executive

24/11/14

Professor Paul Workman has been appointed as Chief Executive and President of The Institute of Cancer Research, London, on a permanent basis.

Make a donation today

A monthly gift can help support our research over several years, so it has the maximum possible benefit for people with cancer.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

With your generous support, we can continue making more discoveries, finding more cures, and saving more lives.
With GiftAid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Our research centres & divisions

Through our close partnerships with The Royal Marsden and other key UK institutions, we're leading a wide breadth of cancer research across eight divisions and more than 25 research centres and strategic initiatives.